As of 2023, Canada's share of scientific publications among the world's top 10% cited in infectious diseases was 11.15%. Forecasts for 2024 to 2028 indicate a gradual decline, with values projected to decrease from 11.01% in 2024 to 10.58% in 2028. The year-on-year variation from 2024 onward shows a consistent decrease of approximately 1%, signaling a slight downtrend. The CAGR over these five years reinforces this trend, highlighting a mild but consistent reduction in citation prominence.
Future trends to watch include Canada's adaptability to emerging global health challenges. Investments in innovative research and international collaborations could influence citation impact, potentially reversing the downward trajectory. Monitoring shifts in funding and research priorities will be crucial in understanding future dynamics in scientific impact.
